Vault and Firsthand have combined platforms! Learn more

cross

Overview

Introduction

Back Bay is a life sciences boutique like no other—one that combines deep expertise in the biopharma and MedTech spaces with guidance in investment banking to create a unique experience for clients and employees alike. Few consulting boutiques offer such rich and exciting opportunities for jobseekers from medical as well as financial backgrounds.

Company Stats


More

Employer Type


More

Size


More

Major Departments/Practice Areas

Biotech...


More

Major Office Locations

Boston, MA (HQ)...


More

President & CEO

About the Company

Back Bay Life Science Advisors provides life science strategy and investment banking to the global life science industry, including pharma, biotech, medtech, academia, and investors.

Back Bay works with companies of all sizes across the US and global life science markets, across every stage, sector, geography, and therapeutic area. Back Bay strategy and banking teams guide companies on technology and drug development, from planning and initial concept to product commercialization, franchising and licensing, M&A, divestiture, and more. 

With headquarters in Boston's Back Bay neighborhood, Back Bay teams are staffed with MDs, PhDs, science and banking experts with proven knowledge and love for new technologies, medicines, and scientific approaches.

Why Work Here


Based out of Boston’s Back Bay—known as “the center of the nation’s biotechnology industry”—we are a boutique-size firm with global reach and reputation. We excel at guiding life science companies and their investors through complex decisions. Our teams work closely with our client partners in leading life science hubs in the United States, Europe and beyond. Our approach is unique in that we among the first and only to integrate life science strategy with investment banking execution so we are a trusted partner through every stage of product development. Our strategy clients more often than not turn into our investment banking clients, as we shepherd products from clinic to development, into broad use and often through M&A needs.